Related Experiment Video
Updated: Mar 3, 2026

06:40
Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
Published on: October 24, 2025
1.0K
Bisphenol A Alternatives in Follicular Fluid: Novel Risk Factors for Ovarian Reserve Dysfunction
Jiale Ren1,2,3, Lan Zhang1,3, Yichang Tian4
1School of Public Health, Capital Medical University, Beijing 100069, China.
ACS Omega
|March 2, 2026
Summary
Bisphenol S (BPS) and other BPA alternatives are prevalent in human follicular fluid, with higher levels in women with PCOS or diminished ovarian reserve, suggesting a role in ovarian dysfunction.
Area of Science:
- Endocrinology and Reproductive Biology
- Environmental Health Sciences
- Analytical Chemistry
Background:
- Bisphenol A (BPA), an endocrine-disrupting chemical, is found in follicular fluid and linked to ovarian reserve dysfunction.
- Limited data exist on the presence and impact of BPA structural analogues within human ovarian follicles.
Purpose of the Study:
- To characterize exposure profiles of BPA and its alternatives in human follicular fluid (FF).
- To assess the association between bisphenol compounds (BPs) and ovarian reserve dysfunction in women with PCOS, DOR, and controls.
Main Methods:
- Collected FF samples from 104 women (15 PCOS, 34 DOR, 55 controls).
- Quantified BPA and 34 alternatives using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).
- Analyzed associations using Spearman's correlation and ordinal logistic regression.
Main Results:
- Identified 24 bisphenol compounds (BPs) in FF; Bisphenol S (BPS) was most prevalent and abundant, exceeding BPA levels.
- Detected 11 BPA and 11 BPS alternatives in FF for the first time.
- Total bisphenol concentration (Σ35BPs) showed a decreasing gradient: PCOS > DOR > control; 14 BPs differed significantly between groups.
- BPA, BPAF, PHBB, DDS, and BPF were associated with abnormal ovarian reserve markers.
Conclusions:
- Confirms widespread presence of BPA alternatives in the ovarian environment.
- Suggests potential role of these alternatives in ovarian dysfunction.
- Highlights need for further mechanistic research and longitudinal studies.

